Kim Lehmkuhl

Kim Lehmkuhl is a policy analyst with the Center for Study of Responsive Law's CEO pay project. Her email is

Articles by this author

Johnson & Johnson’s pay ratio, based on $29.8 million in reported CEO compensation, is a whopping 452:1. (Photo: Floris Van Cauwelaert/Flickr/cc) Views
Tuesday, January 29, 2019
Price-Gouging Drug Company CEOs Must Answer for Their Sky-High Pay
It’s clear to everyone who cares to look that prescription drug price gouging is literally killing patients . Health care executives -- at Big Pharma and pharmacy benefit managers (PBMs) alike -- are moving an inelastic product their customers can’t live without. They know they can charge sick...
Read more